Home › Epilepsy › Arizona › Tucson
Epilepsy clinical trials in Tucson, AZ
4 studies for Epilepsy are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
RecruitingPhase 2/3
- Center for Neurosciences, Tucson
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
RecruitingPhase 3
- University of Arizona - Health Science Center, Tucson
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
RecruitingPhase 1Healthy volunteers welcome
- Center for Neurosciences, Tucson
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- Banner-University of Arizona Medical Center Tucson Comprehensive Epilepsy Program, Tucson
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA20 studies
- Houston, TX16 studies
- New York City, NY14 studies
- Washington, DC13 studies
- Philadelphia, PA12 studies
- Phoenix, AZ10 studies
- Cleveland, OH9 studies
- Miami, FL8 studies
- St. Louis, MO8 studies
- Mountain View, CA8 studies
- Durham, NC8 studies
- Rochester, MN8 studies
Other studies in Tucson
- Breast Cancer20 studies
- Non-Small Cell Lung Cancer17 studies
- Obesity17 studies
- Overweight15 studies
- Metastatic Cancer14 studies
- Cancer (all types)13 studies
- Cardiovascular Disease12 studies
- Prostate Cancer11 studies
- Colorectal Cancer11 studies
- Steatotic Liver Disease10 studies
- Heart Failure10 studies
- High Blood Pressure10 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.